AU2001249317A1 - Compositions and methods for the therapy and diagnosis of ovarian and endometrial cancer - Google Patents
Compositions and methods for the therapy and diagnosis of ovarian and endometrial cancerInfo
- Publication number
- AU2001249317A1 AU2001249317A1 AU2001249317A AU4931701A AU2001249317A1 AU 2001249317 A1 AU2001249317 A1 AU 2001249317A1 AU 2001249317 A AU2001249317 A AU 2001249317A AU 4931701 A AU4931701 A AU 4931701A AU 2001249317 A1 AU2001249317 A1 AU 2001249317A1
- Authority
- AU
- Australia
- Prior art keywords
- ovarian
- diagnosis
- therapy
- compositions
- methods
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 206010014733 Endometrial cancer Diseases 0.000 title 1
- 206010014759 Endometrial neoplasm Diseases 0.000 title 1
- 206010033128 Ovarian cancer Diseases 0.000 title 1
- 206010061535 Ovarian neoplasm Diseases 0.000 title 1
- 238000003745 diagnosis Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 230000002611 ovarian Effects 0.000 title 1
- 238000002560 therapeutic procedure Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Analytical Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Toxicology (AREA)
- Wood Science & Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pathology (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Oncology (AREA)
- Microbiology (AREA)
- Hospice & Palliative Care (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US19071000P | 2000-03-21 | 2000-03-21 | |
| US60/190,710 | 2000-03-21 | ||
| US21374800P | 2000-06-22 | 2000-06-22 | |
| US60/213,748 | 2000-06-22 | ||
| US25727600P | 2000-12-19 | 2000-12-19 | |
| US60/257,276 | 2000-12-19 | ||
| PCT/US2001/009062 WO2001070976A2 (en) | 2000-03-21 | 2001-03-20 | Compositions and methods for the therapy and diagnosis of ovarian and endometrial cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2001249317A1 true AU2001249317A1 (en) | 2001-10-03 |
Family
ID=27392786
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2001249317A Abandoned AU2001249317A1 (en) | 2000-03-21 | 2001-03-20 | Compositions and methods for the therapy and diagnosis of ovarian and endometrial cancer |
Country Status (3)
| Country | Link |
|---|---|
| US (1) | US20020048759A1 (en) |
| AU (1) | AU2001249317A1 (en) |
| WO (1) | WO2001070976A2 (en) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7579160B2 (en) | 1998-03-18 | 2009-08-25 | Corixa Corporation | Methods for the detection of cervical cancer |
| AU2002318112B2 (en) | 2001-04-10 | 2007-12-06 | Agensys, Inc. | Nucleic acids and corresponding proteins useful in the detection and treatment of various cancers |
| DE10215320A1 (en) * | 2002-04-02 | 2003-10-23 | Metagen Pharmaceuticals Gmbh | Diagnosis of uterine or ovarian cancer, by detecting overexpression of TFF3 protein or nucleic acid, also treatment using TTF3 inhibitors |
| DK1545561T3 (en) | 2002-10-02 | 2010-08-02 | Univ British Columbia | Oligonucleotides for the treatment of prostate and other cancers |
| US8722872B2 (en) | 2002-10-02 | 2014-05-13 | The University Of British Columbia | Compositions and methods for treatment of prostate and other cancers |
| AU2003900747A0 (en) * | 2003-02-18 | 2003-03-06 | Garvan Institute Of Medical Research | Diagnosis and treatment of pancreatic cancer |
| JP4643450B2 (en) | 2003-08-08 | 2011-03-02 | 株式会社ペルセウスプロテオミクス | Cancer high expression gene |
| WO2008106781A1 (en) | 2007-03-05 | 2008-09-12 | The University Of British Columbia | Treatment of squamous cell carcinoma with hsp27 antisense oligonucleotides and radiotherapy |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5976799A (en) * | 1996-03-21 | 1999-11-02 | The Board Of Trustees Of The University Of Arkansas | Early detection of ovarian carcinoma using P16 gene products |
| DE19817557A1 (en) * | 1998-04-09 | 1999-10-21 | Metagen Gesellschaft Fuer Genomforschung Mbh | Human nucleic acid sequences from ovarian tumor tissue |
| DE19817948A1 (en) * | 1998-04-17 | 1999-10-21 | Metagen Gesellschaft Fuer Genomforschung Mbh | New nucleic acid sequences expressed in uterine cancer tissues, and derived polypeptides, for treatment of uterine and endometrial cancer and identification of therapeutic agents |
-
2001
- 2001-03-20 AU AU2001249317A patent/AU2001249317A1/en not_active Abandoned
- 2001-03-20 WO PCT/US2001/009062 patent/WO2001070976A2/en not_active Ceased
- 2001-03-21 US US09/813,358 patent/US20020048759A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20020048759A1 (en) | 2002-04-25 |
| WO2001070976A3 (en) | 2002-10-03 |
| WO2001070976A2 (en) | 2001-09-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2001265296A1 (en) | Compositions and methods for the therapy and diagnosis of ovarian cancer | |
| AU2001231199A1 (en) | Compositions and methods for the early diagnosis of ovarian cancer | |
| AU2001249549A1 (en) | Compositions and methods for the therapy and diagnosis of prostate cancer | |
| AU2001268259A1 (en) | Compositions and methods for the therapy and diagnosis of colon cancer | |
| AU2001269766A1 (en) | Compositions and methods for the therapy and diagnosis of colon cancer | |
| AU2002251844A1 (en) | Compositions and methods for the therapy and diagnosis of colon cancer | |
| AU2002251841A1 (en) | Compositions and methods for the therapy and diagnosis of pancreatic cancer | |
| AU2001261007A1 (en) | Compositions and methods for the therapy and diagnosis of lung cancer | |
| AU3983201A (en) | Compositions and methods for the early diagnosis of ovarian cancer | |
| AU3491001A (en) | Compositions and methods for the early diagnosis of ovarian cancer | |
| AU1656501A (en) | Compositions and methods for the therapy and diagnosis of prostate cancer | |
| AU2002218770A1 (en) | Compositions and methods for the therapy and diagnosis of lung cancer | |
| AU2002311909A1 (en) | Compositions and methods for the therapy and diagnosis of lung cancer | |
| AU2002254482A1 (en) | Compositions and methods for the therapy and diagnosis of kidney cancer | |
| AU2001280982A1 (en) | Compositions and methods for the therapy and diagnosis of colon cancer | |
| AU2002303219A1 (en) | Compositions and methods for the therapy and diagnosis of cancer | |
| AU2002246519A1 (en) | Compositions and methods for the therapy and diagnosis of colon cancer | |
| AU2001252945A1 (en) | Compositions and methods for therapy and diagnosis of colon cancer | |
| AU2002359330A1 (en) | Compositions and methods for the therapy and diagnosis of lung cancer | |
| AU2001259062A1 (en) | Compositions and methods for the therapy and diagnosis of lung cancer | |
| AU2002239431A1 (en) | Compositions and methods for the therapy and diagnosis of ovarian cancer | |
| AU2002313726A1 (en) | Compositions and methods for the therapy and diagnosis of breast cancer | |
| AU2001290518A1 (en) | Compositions and methods for the therapy and diagnosis of colon cancer | |
| AU3483001A (en) | Compositions and methods for the therapy and diagnosis of ovarian cancer | |
| AU2001249317A1 (en) | Compositions and methods for the therapy and diagnosis of ovarian and endometrial cancer |